Resources from the same session
50MO - Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
Presenter: David König
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
66MO - Early complete metabolic response predicts long-term efficacy after adoptive cell therapy using tumor-infiltrating lymphocytes
Presenter: Troels Borch
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
163MO - Single-cell T cell dynamics induced by neoadjuvant nivolumab +/- ipilimumab in early triple negative breast cancer with tumor-infiltrating lymphocytes (BELLINI trial)
Presenter: Olga Isaeva
Session: Mini Oral session
Resources:
Abstract
67MO - Neoadjuvant and Adjuvant Toripalimab in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial
Presenter: Haiqiang Mai
Session: Mini Oral session
Resources:
Abstract
Invited Discussant 163MO
Presenter: Eliane Piaggio
Session: Mini Oral session
Resources:
Slides
Webcast
LBA4 - Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma
Presenter: Thomas Marron
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
120MO - Adjuvant Pembrolizumab versus Placebo for Early-Stage NSCLC After Resection and Optional Chemotherapy: Updated Results From PEARLS/KEYNOTE-091
Presenter: Benjamin Besse
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast